Yttrium-90 distribution following radiosynoviorthesis of the knee joint in rheumatoid arthritis patients: a SPECT/CT study

被引:4
作者
Bielinska, A. [1 ]
Korkosz, M. [2 ]
Gasowski, J. [3 ]
Tomaszuk, M. [4 ]
Staszczak-Sowa, A. [5 ]
Kwasny-Krochin, B. [1 ]
Buziak-Bereza, M. [5 ]
Hubalewska-Dydejczyk, A. [5 ]
Grodzicki, T. [3 ]
机构
[1] Jagiellonian Univ, Coll Med, Dept Rheumatol & Balneol, PL-31501 Krakow, Poland
[2] Jagiellonian Univ, Coll Med, Dept Internal Med & Gerontol, Div Rheumatol, PL-31501 Krakow, Poland
[3] Jagiellonian Univ, Coll Med, Dept Internal Med & Gerontol, PL-31501 Krakow, Poland
[4] Univ Hosp Krakow, Dept Endocrinol, Nucl Med Unit, Krakow, Poland
[5] Jagiellonian Univ, Coll Med, Dept Endocrinol, Nucl Med Unit, PL-31501 Krakow, Poland
关键词
Rheumatoid arthritis; Radiosynoviorthesis; Yttrium-90; isotope; SPECT/CT; RADIATION SYNOVECTOMY;
D O I
10.1007/s12149-014-0827-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To examine yttrium-90 distribution 1 and 72 h following its injection into a knee joint in patients with rheumatoid arthritis (RA). In 14 RA patients we injected yttrium-90 into the affected knee joint using lateral approach. To assess the radioisotope distribution in the joint, the superimposed sequential SPECT and CT imaging was performed 1 and 72 h after the injection. We analyzed the percentage of radioisotope distribution in three predefined compartments of the knee joint (lower, upper medial, upper lateral). After 1 and 72 h, the mean percentage distributions were, respectively, 7.14 and 23.07 % in lower; 21.42 and 15.38 % in upper medial, and 71.42 and 61.53 % in upper lateral compartment. The percentage of isotope deposition did not change significantly with time in any of the compartments (all p > 0.26). The deposition of isotope, both at 1 and 72 h, was significantly greater in upper lateral compartment, where the injection was performed, than in all other compartments (all p < 0.05). Using the SPECT/CT hybrid method, we proved that the majority of isotope is located at the compartment adjacent to the injection. Two injections targeting different compartments might improve the clinical efficacy of the procedure.
引用
收藏
页码:688 / 692
页数:5
相关论文
共 10 条
[1]  
[Anonymous], 2008, CLIN APPL SPECT CT N
[2]   Radiation synovectomy with 90Y colloid in the therapy of recurrent knee joint effusions in patients with inflammatory joint diseases [J].
Chrapko, Beata ;
Zwolak, Robert ;
Nocun, Anna ;
Golebiewska, Renata ;
Majdan, Maria .
RHEUMATOLOGY INTERNATIONAL, 2007, 27 (08) :729-734
[3]  
Clunie G, 2003, Eur J Nucl Med Mol Imaging, V30, pBP12
[4]   Yttrium radiosynoviorthesis in the treatment of knee arthritis in rheumatoid arthritis: a systematic review [J].
Heuft-Dorenbosch, LLJ ;
de Vet, HCW ;
van der Linden, S .
ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (08) :583-586
[5]   The intra-articular distribution of 90yttrium does not influence the clinical outcome of radiation synovectomy of the knee [J].
Jahangier, Z. N. ;
van der Zant, F. M. ;
Jacobs, J. W. G. ;
Riedstra, H. G. ;
Gommans, G. M. M. ;
Verzijlbergen, J. F. ;
Bijlsma, J. W. J. ;
van Isselt, J. W. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (08) :1110-1112
[6]  
Jurgilewicz Dorota, 2012, Nucl Med Rev Cent East Eur, V15, P156
[7]   Therapeutic status of radiosynoviorthesis of the knee with yttrium [90Y] colloid in rheumatoid arthritis and related indications [J].
Kampen, W. U. ;
Voth, M. ;
Pinkert, J. ;
Krause, A. .
RHEUMATOLOGY, 2007, 46 (01) :16-24
[8]  
Pirich C, 1999, J NUCL MED, V40, P1277
[9]   Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association Classification Criteria for Rheumatoid Arthritis in an Early Arthritis Cohort in New Zealand [J].
Raja, Rafi ;
Chapman, Peter T. ;
O'Donnell, John L. ;
Ipenburg, Jan ;
Frampton, Chris ;
Hurst, Miriam ;
Stamp, Lisa K. .
JOURNAL OF RHEUMATOLOGY, 2012, 39 (11) :2098-2103
[10]   Distribution of radiation in synovectomy of the knee with 166Ho-FHMA using image fusion [J].
Vuorela, J ;
Kauppinen, T ;
Sokka, T .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2005, 20 (03) :333-337